» Articles » PMID: 12970352

Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Sep 13
PMID 12970352
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Anterior pituitary cells express nucleotide-gated G protein-coupled P2 receptors (P2YRs) and cation-conducting channels (P2XRs). However, the identification of P2 receptors subtypes and their native ligands, and the distribution and function of these receptors within the secretory and non-secretory pituitary cells has been incompletely characterized. The focus in this study was on lactotroph subpopulation of cells. ATP and ADP, but not UTP and UDP, triggered calcium signaling in a majority (85%) of lactotrophs and prolactin release in mixed pituitary cells. Consistent with the role of P2 receptors in signaling and secretion, the actions of ATP and ADP were abolished in the presence of apyrase, an ectonucleotidase. Transcripts for Gq-coupled calcium-mobilizing P2Y1R, P2Y2R, P2Y4R, and P2Y6R, as well as Gi-coupled P2Y12R, were identified in mixed anterior pituitary cells. The ligand-selectivity profile of calcium mobilization-dependent signaling and prolactin secretion and the blockade of these responses by pyridoxal 5-phosphate 6-azophenyl-2',4'-disulphonic acid indicated that P2Y1R mediates the stimulatory action of ATP and ADP. Within the channels expressed in anterior pituitary (P2X2R, P2X3R, P2X4R, and P2X7R), the P2X4R subtype provides a major pathway for calcium influx-dependent signaling and prolactin secretion. This conclusion was based on comparison of native to recombinant channels with respect to their ligand preference, sensitivity to pyridoxal 5-phosphate 6-azophenyl-2',4'-disulphonic acid, and the rates of calcium signal desensitization.

Citing Articles

ADP-mediated Modulation of Intracellular Calcium Responses in Chromaffin Cells: The Role of Ectonucleoside Triphosphate Diphosphohydrolase 2 on Rat Adrenal Medulla Function.

Maesawa S, Yokoyama T, Sakanoue W, Yamamoto Y, Hirakawa M, Shiraishi H J Histochem Cytochem. 2023; 72(1):41-60.

PMID: 38158780 PMC: 10795562. DOI: 10.1369/00221554231221872.


Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases.

Braganca B, Correia-de-Sa P Int J Mol Sci. 2020; 21(14).

PMID: 32679900 PMC: 7404342. DOI: 10.3390/ijms21145005.


Pharmacological and genetic characterisation of the canine P2X4 receptor.

Sophocleous R, Berg T, Finol-Urdaneta R, Sluyter V, Keshiya S, Bell L Br J Pharmacol. 2020; 177(12):2812-2829.

PMID: 32017039 PMC: 7236074. DOI: 10.1111/bph.15009.


A peripherally restricted P2Y receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism.

Brott D, Andersson H, Stewart J, Ewart L, Christoph G, Harleman J Toxicol Rep. 2017; 1:1202-1212.

PMID: 28962330 PMC: 5598522. DOI: 10.1016/j.toxrep.2014.11.010.


Neurotransmitter receptors as signaling platforms in anterior pituitary cells.

Zemkova H, Stojilkovic S Mol Cell Endocrinol. 2017; 463:49-64.

PMID: 28684290 PMC: 5752632. DOI: 10.1016/j.mce.2017.07.003.